Weidong Xiong

2.2k citations

39 papers · 1.6k indexed · 1 hit paper · h-index 20

Molecular Biology top 10%
Genetics top 5%
Immunology top 5%
Oncology top 10%
Genetics top 5%

Co-authors: María G. Castro Pedro R. Löwenstein James F. Curtin Mariana Puntel Kurt M. Kroeger Chunyan Liu Marianela Candolfi Gwendalyn D. King
Topics: Virus-based gene therapy research (20 papers)RNA Interference and Gene Delivery (13 papers)CAR-T cell therapy research (8 papers)
Cited by: Immunology Genetics
Journals: Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaThe Journal of Cell Biology
Partner nations: United States China United Kingdom

In The Last Decade

Weidong Xiong

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets

2023 124 citations Yongchao Zhao, Weidong Xiong et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Weidong Xiong

Since Specialization

Citations

This map shows the geographic impact of Weidong Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Xiong more than expected).

Fields of papers citing papers by Weidong Xiong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Xiong. The network helps show where Weidong Xiong may publish in the future.

Co-authorship network of co-authors of Weidong Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Xiong. A scholar is included among the top collaborators of Weidong Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Xiong. Weidong Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization 2025 ·European Heart Journal ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Weidong Xiong,(unknown),Xin Deng,(unknown),Xinyu Zhao,(unknown),Chang Li,(unknown),(unknown),(unknown),Junbo Ge	0
2	Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay 2024 ·Journal of Molecular and Cellular Cardiology ·(unknown),(unknown),(unknown),Chaofu Li,Weidong Xiong,Yiqing Hu,(unknown),(unknown),(unknown),Chaozhong Li,(unknown),(unknown),Yongchao Zhao,Bei Shi	8
3	Insulin-like growth factor-2 mRNA-binding protein 2 facilitates post-ischemic angiogenesis by increasing the stability of fibroblast growth factor 2 mRNA and its protein expression 2024 ·Heliyon ·Shuai Ma,Yiqing Hu,(unknown),Weidong Xiong,Xinyu Xu,(unknown),Ying Wang,(unknown),(unknown),(unknown),Yongchao Zhao	1
4	Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targetsbreakdown → 2023 ·Signal Transduction and Targeted Therapy ·Yongchao Zhao,Weidong Xiong,Chaofu Li,(unknown),Hao Lu,Shuai Song,You Zhou,Yiqing Hu,Bei Shi,Junbo Ge	124
5	Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload‐Induced Heart Disease 2023 ·Advanced Science ·Chaofu Li,Yongchao Zhao,Fuhai Li,Zimu Wang,(unknown),(unknown),Weidong Xiong,(unknown),Han Chen,Fei Xu,(unknown),Zhiqiang Pei,Yan Wang,Bei Shi,Li Shen,Junbo Ge	6
6	Methyltransferase like 3-mediated N6-methylatidin methylation inhibits vascular smooth muscle cells phenotype switching via promoting phosphatidylinositol 3-kinase mRNA decay 2022 ·Frontiers in Cardiovascular Medicine ·Yongchao Zhao,(unknown),Chaofu Li,Xianping Long,(unknown),(unknown),Weidong Xiong,Ning Gu,(unknown),(unknown),Bei Shi	12
7	Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer 2019 ·SHILAP Revista de lepidopterología ·Hui Ren,Zhaolin Chen,Lawei Yang,Weidong Xiong,(unknown),(unknown),Ertao Zhai,Li Ding,Yi He,Xinming Song	5
8	Identification of aPRXvariant in a Chinese family with congenital cataract by exome sequencing 2016 ·QJM ·Lamei Yuan,Jinyao Yi,(unknown),Hongbo Xu,Xing Wang Deng,Weidong Xiong,Jingjing Xiao,(unknown),(unknown),Ye Chen‐Izu,Hao Deng	14
9	Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model 2012 ·Neurotherapeutics ·Yohei Mineharu,(unknown),Kader Yagiz,Marianela Candolfi,Kurt M. Kroeger,Weidong Xiong,Mariana Puntel,Chunyan Liu,E Lévy,(unknown),Adrina Kocharian,James P. Allison,Michael A. Curran,Pedro R. Löwenstein,María G. Castro	24
10	Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation 2011 ·Anti-Cancer Agents in Medicinal Chemistry ·Marianela Candolfi,Kurt M. Kroeger,Weidong Xiong,Chunyan Liu,Mariana Puntel,Kader Yagiz,(unknown),Yohei Mineharu,David Foulad,(unknown),Hikmat Assi,Gregory J. Baker,Pedro R. Löwenstein,María G. Castro	12
11	Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen 2011 ·Molecular Therapy ·Gwendalyn D. King,(unknown),Daniel Larocque,(unknown),Weidong Xiong,Chunyan Liu,Nicholas Sanderson,Kurt M. Kroeger,María G. Castro,Pedro R. Löwenstein	37
12	Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical Trial 2010 ·PLoS ONE ·Weidong Xiong,Marianela Candolfi,Chunyan Liu,A.K.M. Ghulam Muhammad,Kader Yagiz,Mariana Puntel,Peter F. Moore,(unknown),John Ding‐E Young,(unknown),(unknown),G. Elizabeth Pluhar,John R. Ohlfest,Kolja Wawrowsky,Pedro R. Löwenstein,María G. Castro	26
13	Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity 2009 ·Clinical Cancer Research ·Marianela Candolfi,Kader Yagiz,David Foulad,(unknown),(unknown),A.K.M. Ghulam Muhammad,Mariana Puntel,Kurt M. Kroeger,Chunyan Liu,Sharon Lee,James F. Curtin,Gwendalyn D. King,Jonathan Lerner,Katsuaki Sato,Yohei Mineharu,Weidong Xiong,Pedro R. Löwenstein,María G. Castro	80
14	HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression 2009 ·PLoS Medicine ·James F. Curtin,Naiyou Liu,Marianela Candolfi,Weidong Xiong,Hikmat Assi,Kader Yagiz,Matthew R. Edwards,Kathrin S. Michelsen,Kurt M. Kroeger,Chunyan Liu,A.K.M. Ghulam Muhammad,Mary C. Clark,Moshe Arditi,Begonya Comin-Anduix,Antoni Ribas,Pedro R. Löwenstein,María G. Castro	288
15	Regulated Expression of Adenoviral Vectors-Based Gene Therapies 2008 ·Humana Press eBooks ·James F. Curtin,Marianela Candolfi,Mariana Puntel,Weidong Xiong,A.K.M. Ghulam Muhammad,Kurt M. Kroeger,Sonali Mondkar,Chunyan Liu,(unknown),Pedro R. Löwenstein,María G. Castro	9
16	Gene Therapy for Pituitary Tumors 2005 ·Current Gene Therapy ·Adriana Seilicovich,Daniel Pisera,Sandra A. Sciascia,Marianela Candolfi,Mariana Puntel,Weidong Xiong,Gabriela Jaita,María G. Castro	5
17	Regulatable gene expression systems for gene therapy applications: progress and future challenges 2005 ·Molecular Therapy ·Shyam Goverdhana,Mariana Puntel,Weidong Xiong,(unknown),Carlos Barcia,James F. Curtin,(unknown),Sonali Mondkar,Gwendalyn D. King,Jinwei Hu,Sandra A. Sciascia,Marianela Candolfi,(unknown),Pedro R. Löwenstein,María G. Castro	215
18	Inflammatory and Anti-glioma Effects of an Adenovirus Expressing Human Soluble Fms-like Tyrosine Kinase 3 Ligand (hsFlt3L): Treatment with hsFlt3L Inhibits Intracranial Glioma Progression 2004 ·Molecular Therapy ·Sumia Ali,James F. Curtin,Jeffrey M. Zirger,Weidong Xiong,Gwendalyn D. King,Carlos Barcia,Chunyan Liu,Mariana Puntel,Shyam Goverdhana,Pedro R. Löwenstein,María G. Castro	71
19	Adenovirus expression of IL-1 and NF-κB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expression 2003 ·Molecular Therapy ·Daniel Stone,Weidong Xiong,Judith C. Williams,Anne David,Pedro R. Löwenstein,María G. Castro	9
20	Recent developments in gene therapy: applications for the treatment of pituitary tumours 1999 ·Best Practice & Research Clinical Endocrinology & Metabolism ·María G. Castro,J.R. Davis,Weidong Xiong,Pedro R. Löwenstein	6

About Weidong Xiong

Weidong Xiong is a scholar working on Genetics, Immunology and Cancer Research, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (13 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Immunology (492 citations), Genetics (596 citations) and Genetics (184 citations). Weidong Xiong has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include María G. Castro, Pedro R. Löwenstein, James F. Curtin, Mariana Puntel, Kurt M. Kroeger, Chunyan Liu, Marianela Candolfi, Gwendalyn D. King, A.K.M. Ghulam Muhammad and Kader Yagiz. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact